Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 153 articles:
HTML format
Text format



Single Articles


    November 2019
  1. AIHARA M, Lu F, Kawata H, Tanaka Y, et al
    Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
    J Ocul Pharmacol Ther. 2019 Nov 1. doi: 10.1089/jop.2019.0044.
    PubMed     Text format     Abstract available



  2. Correction to: In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment, by La Gatta, A., Corsuto, L., Salzillo, R., D'Agostino, A., De Rosa, M., Bracco, A., and Schiraldi, C. J Ocul Pharmacol Ther
    J Ocul Pharmacol Ther. 2019;35:522.
    PubMed     Text format    


    October 2019
  3. OZDEMIR MH, Elbay A, Kirik F, Ekinci C, et al
    Regression of Serous Macular Detachment After Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2019 Oct 24. doi: 10.1089/jop.2019.0028.
    PubMed     Text format     Abstract available


  4. SEVEN E, Yildiz S, Tekin S, Altas AS, et al
    Effect of Insulin Therapy on Ocular Biometric Parameters in Diabetic Patients.
    J Ocul Pharmacol Ther. 2019 Oct 23. doi: 10.1089/jop.2019.0070.
    PubMed     Text format     Abstract available


  5. GRZYBOWSKI A, Brockmann T, Kanclerz P, Pleyer U, et al
    Dexamethasone Intraocular Suspension: A Long-Acting Therapeutic for Treating Inflammation Associated with Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Oct 23. doi: 10.1089/jop.2019.0072.
    PubMed     Text format     Abstract available


  6. SINGHAL R, Luo A, O'Rourke T, Scott IU, et al
    Transzonular Triamcinolone-Moxifloxacin Versus Topical Drops for the Prophylaxis of Postoperative Inflammation After Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Oct 15. doi: 10.1089/jop.2019.0097.
    PubMed     Text format     Abstract available


  7. BEZZINA AD, Carbonaro F
    Factors Predicting Treatment Response in Anti-Vascular Endothelial Growth Factor Naive Diabetic Macular Edema Patients Treated with Intravitreal Bevacizumab.
    J Ocul Pharmacol Ther. 2019 Oct 11. doi: 10.1089/jop.2018.0112.
    PubMed     Text format     Abstract available


  8. MAZZILLI JL, Snook JD, Simmons K, Domozhirov AY, et al
    A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    J Ocul Pharmacol Ther. 2019 Oct 9. doi: 10.1089/jop.2019.0039.
    PubMed     Text format     Abstract available


  9. KLARLUND JK, Callaghan JD, Stella NA, Kowalski RP, et al
    Use of Collagen Binding Domains to Deliver Molecules to the Cornea.
    J Ocul Pharmacol Ther. 2019 Oct 9. doi: 10.1089/jop.2019.0065.
    PubMed     Text format     Abstract available


  10. JAYAGOPAL A, Ragelle H
    Introduction to JOPT Special Issue: Next-Generation Tissue Engineering-Inspired Models for Ophthalmic Drug Discovery.
    J Ocul Pharmacol Ther. 2019 Oct 1. doi: 10.1089/jop.2019.0101.
    PubMed     Text format    


  11. BLUMENTHAL EZ, Cordeiro MF, Shmetterer L, Levkovitch Verbin H, et al
    ISOPT Clinical Hot Topic Panel Discussion on Glaucoma.
    J Ocul Pharmacol Ther. 2019;35:441-446.
    PubMed     Text format     Abstract available


  12. NEUMANN R, Nguyen QD, Kramer M, Zierhut M, et al
    ISOPT Clinical Hot Topic Panel Discussion on Uveitis and Inflammation.
    J Ocul Pharmacol Ther. 2019;35:433-440.
    PubMed     Text format     Abstract available


  13. ASBELL PA, Aquavella JV, Hamrah P, Pepose JS, et al
    ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease.
    J Ocul Pharmacol Ther. 2019;35:447-456.
    PubMed     Text format     Abstract available


  14. KUPPERMANN BD, Bernstein P, Mones J, Do DV, et al
    ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases.
    J Ocul Pharmacol Ther. 2019;35:424-432.
    PubMed     Text format     Abstract available


    September 2019
  15. VALERA-CORNEJO DA, Vega-Estrada A, Alio JL
    Invasive Pharmacology Outcomes with Different Corneal Cross-Linking Protocols: A Review.
    J Ocul Pharmacol Ther. 2019 Sep 24. doi: 10.1089/jop.2018.0144.
    PubMed     Text format     Abstract available


  16. GONZALEZ-DE LA ROSA A, Navarro-Partida J, Altamirano-Vallejo JC, Jauregui-Garcia GD, et al
    Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery.
    J Ocul Pharmacol Ther. 2019 Sep 5. doi: 10.1089/jop.2019.0032.
    PubMed     Text format     Abstract available


    August 2019
  17. UCHIDA T, Ueta T, Honjo M, Aihara M, et al
    The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells.
    J Ocul Pharmacol Ther. 2019 Aug 28. doi: 10.1089/jop.2018.0152.
    PubMed     Text format     Abstract available


  18. SHRESTHA A, Allen BN, Wiley LA, Tucker BA, et al
    Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.
    J Ocul Pharmacol Ther. 2019 Aug 16. doi: 10.1089/jop.2018.0146.
    PubMed     Text format     Abstract available


  19. MATSUSHIMA R, Noma H, Yasuda K, Goto H, et al
    Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0011.
    PubMed     Text format     Abstract available


  20. SALIMI A, Winter A, Li C, Harasymowycz P, et al
    Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0019.
    PubMed     Text format     Abstract available


  21. HWANG HB, Kim SY, Ohn K, Kim SY, et al
    Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2019.0037.
    PubMed     Text format     Abstract available


  22. SMYTH-MEDINA R, Johnston J, Devries DK, Jasper A, et al
    Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials.
    J Ocul Pharmacol Ther. 2019 Aug 2. doi: 10.1089/jop.2018.0154.
    PubMed     Text format     Abstract available


    July 2019
  23. WEISS SL, Kramer WG
    Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    J Ocul Pharmacol Ther. 2019 Jul 29. doi: 10.1089/jop.2018.0106.
    PubMed     Text format     Abstract available


    June 2019
  24. PLUSS CJ, Kustermann S
    A Human Three-Dimensional In Vitro Model of Lens Epithelial Cells as a Model to Study Mechanisms of Drug-Induced Posterior Subcapsular Cataracts.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2019.0010.
    PubMed     Text format     Abstract available


  25. CRUL M, Zandvliet A, Moes JR, Veenbaas T, et al
    Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2019.0042.
    PubMed     Text format     Abstract available


  26. SIMSEK C, Dogru M, Shinzawa M, Den S, et al
    The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2018.0130.
    PubMed     Text format     Abstract available


  27. KOMPELLA UB, Domb A, Urtti A, Jayagopal A, et al
    Ocular Drug Delivery: Nanotechnology, Physical and Chemical Methods, Vitreous Drug Binding, and Aging Eye.
    J Ocul Pharmacol Ther. 2019 Jun 28. doi: 10.1089/jop.2018.0138.
    PubMed     Text format     Abstract available


  28. TAKHAR JS, Pawar VK, Marneris AG, Doan TA, et al
    When to Consider Bisphosphonates in Patients on Steroids for Chronic Ocular Inflammatory Conditions.
    J Ocul Pharmacol Ther. 2019 Jun 26. doi: 10.1089/jop.2019.0058.
    PubMed     Text format    


  29. LABETOULLE M, Rousseau A, M'Garrech M, Kaswin G, et al
    Efficacy of a Topical Heparan Sulfate Mimetic Polymer on Ocular Surface Discomfort in Patients with Cogan's Epithelial Basement Membrane Dystrophy.
    J Ocul Pharmacol Ther. 2019 Jun 21. doi: 10.1089/jop.2019.0015.
    PubMed     Text format     Abstract available


  30. KONDA SM, Kaufman PL
    New Therapies to Reduce Intraocular Pressures.
    J Ocul Pharmacol Ther. 2019 Jun 20. doi: 10.1089/jop.2019.0059.
    PubMed     Text format    


  31. SERNA-OJEDA JC, Santana-Cruz O, Quiroz-Casian N, Gonzalez-Mendoza E, et al
    Pain Management in Corneal Collagen Crosslinking for Keratoconus: A Comparative Case Series.
    J Ocul Pharmacol Ther. 2019 Jun 19. doi: 10.1089/jop.2019.0021.
    PubMed     Text format     Abstract available


  32. FENTON OS, Paolini M, Andresen JL, Muller FJ, et al
    Outlooks on Three-Dimensional Printing for Ocular Biomaterials Research.
    J Ocul Pharmacol Ther. 2019 Jun 18. doi: 10.1089/jop.2018.0142.
    PubMed     Text format     Abstract available


  33. WRIGHT CB, Becker SM, Low LA, Tagle DA, et al
    Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
    J Ocul Pharmacol Ther. 2019 Jun 5. doi: 10.1089/jop.2018.0139.
    PubMed     Text format     Abstract available


    May 2019
  34. RAGELLE H, Goncalves A, Kustermann S, Antonetti DA, et al
    Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models.
    J Ocul Pharmacol Ther. 2019 May 29. doi: 10.1089/jop.2019.0017.
    PubMed     Text format     Abstract available


  35. LI C, Feng X, Wen X, Li Y, et al
    A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization.
    J Ocul Pharmacol Ther. 2019 May 15. doi: 10.1089/jop.2018.0097.
    PubMed     Text format     Abstract available


  36. SEBBAG L, Yan Y, Smith JS, Allbaugh RA, et al
    Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.
    J Ocul Pharmacol Ther. 2019 May 9. doi: 10.1089/jop.2019.0020.
    PubMed     Text format     Abstract available


  37. PERAGINE C, Walker SAN, Walker S, Palmay L, et al
    Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success.
    J Ocul Pharmacol Ther. 2019 May 8. doi: 10.1089/jop.2019.0013.
    PubMed     Text format     Abstract available


  38. AASEN DM, Vergara MN
    New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids.
    J Ocul Pharmacol Ther. 2019 May 6. doi: 10.1089/jop.2018.0140.
    PubMed     Text format     Abstract available


    April 2019
  39. CHO YK, Shin EY, Uehara H, Ambati B, et al
    Antiangiogenesis Effect of Albendazole on the Cornea.
    J Ocul Pharmacol Ther. 2019 Apr 27. doi: 10.1089/jop.2018.0103.
    PubMed     Text format     Abstract available


  40. WOODWARD DF, Wang JW, Coleman RA, Woodrooffe AJ, et al
    A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
    J Ocul Pharmacol Ther. 2019 Apr 25. doi: 10.1089/jop.2018.0126.
    PubMed     Text format     Abstract available


  41. TASKAR P, Adelli G, Patil A, Lakhani P, et al
    Analog Derivatization of Cannabidiol for Improved Ocular Permeation.
    J Ocul Pharmacol Ther. 2019 Apr 18. doi: 10.1089/jop.2018.0141.
    PubMed     Text format     Abstract available


  42. YANG L, Qiu Y, Liu J, Lin R, et al
    Retinal Transcriptome Analysis in the Treatment of Endotoxin-Induced Uveitis with Tetramethylpyrazine Eye Drops.
    J Ocul Pharmacol Ther. 2019 Apr 17. doi: 10.1089/jop.2018.0105.
    PubMed     Text format     Abstract available


  43. BANTSEEV V, Miller PE, Nork TM, Rasmussen CA, et al
    Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys.
    J Ocul Pharmacol Ther. 2019 Apr 9. doi: 10.1089/jop.2018.0149.
    PubMed     Text format     Abstract available


  44. ABDEL-MEGUID AAE, Gabr AF, Said MM, Hamid Nassef MAE, et al
    Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.
    J Ocul Pharmacol Ther. 2019 Apr 5. doi: 10.1089/jop.2018.0088.
    PubMed     Text format     Abstract available


    March 2019
  45. BROWN GC, Brown MM
    Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Mar 28. doi: 10.1089/jop.2018.0114.
    PubMed     Text format     Abstract available


  46. HAN DP, Skumatz C, Besharse JC, Kassem IS, et al
    Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency.
    J Ocul Pharmacol Ther. 2019 Mar 27. doi: 10.1089/jop.2018.0085.
    PubMed     Text format     Abstract available


  47. CAVET ME, Glogowski S, Lowe ER, Phillips E, et al
    Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.
    J Ocul Pharmacol Ther. 2019 Mar 23. doi: 10.1089/jop.2018.0136.
    PubMed     Text format     Abstract available


  48. WOLFRAM C, Stahlberg E, Pfeiffer N
    Patient-Reported Nonadherence with Glaucoma Therapy.
    J Ocul Pharmacol Ther. 2019 Mar 21. doi: 10.1089/jop.2018.0134.
    PubMed     Text format     Abstract available


  49. WANG T, Li W, Zhong L, Ye H, et al
    Evaluation of the Effects of Biohcly in an In Vivo Model of Mechanical Wounds in the Rabbit Cornea.
    J Ocul Pharmacol Ther. 2019 Mar 19. doi: 10.1089/jop.2018.0098.
    PubMed     Text format     Abstract available


  50. ITAKURA T, Webster A, Chintala SK, Wang Y, et al
    GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Mar 11. doi: 10.1089/jop.2018.0135.
    PubMed     Text format     Abstract available


    February 2019
  51. CHO HJ, Jung SH, Cho S, Han JO, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy.
    J Ocul Pharmacol Ther. 2019 Feb 26. doi: 10.1089/jop.2018.0107.
    PubMed     Text format     Abstract available


  52. TEKIN S, Seven E, Batur M
    Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2019 Feb 13. doi: 10.1089/jop.2018.0124.
    PubMed     Text format     Abstract available


    January 2019
  53. LEE SS, Dibas M, Almazan A, Robinson MR, et al
    Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.
    J Ocul Pharmacol Ther. 2019 Jan 30. doi: 10.1089/jop.2018.0095.
    PubMed     Text format     Abstract available


  54. GEORGAKOPOULOS CD, Plotas P, Kagkelaris K, Tsapardoni F, et al
    Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0113.
    PubMed     Text format     Abstract available


  55. ARBABI A, Liu A, Ameri H
    Gene Therapy for Inherited Retinal Degeneration.
    J Ocul Pharmacol Ther. 2019 Jan 28. doi: 10.1089/jop.2018.0087.
    PubMed     Text format     Abstract available


  56. NELSON WW, Lima AF, Kranyak J, Opong-Owusu B, et al
    Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.
    J Ocul Pharmacol Ther. 2019 Jan 24. doi: 10.1089/jop.2018.0090.
    PubMed     Text format     Abstract available


  57. YANG KB, Zhang H, Li SJ, Cao JJ, et al
    Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
    J Ocul Pharmacol Ther. 2019 Jan 22. doi: 10.1089/jop.2018.0093.
    PubMed     Text format     Abstract available


  58. SAMY KE, Cao Y, Kim J, Konichi da Silva NR, et al
    Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0096.
    PubMed     Text format     Abstract available


  59. GONZALEZ-DE LA ROSA A, Navarro-Partida J, Altamirano-Vallejo JC, Hernandez-Gamez AG, et al
    Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
    J Ocul Pharmacol Ther. 2019 Jan 7. doi: 10.1089/jop.2018.0101.
    PubMed     Text format     Abstract available


  60. CHUA PY, Clare G, Leslie T
    Re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study" by Jin and Lee (J. Ocul. Pharmacol. Ther. 34:274-279, 2018).
    J Ocul Pharmacol Ther. 2019;35:3-4.
    PubMed     Text format    


  61. JIN SW
    Response to Chua et al. re: "The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study".
    J Ocul Pharmacol Ther. 2019;35:5.
    PubMed     Text format    


  62. RODIER JT, Tripathi R, Fink MK, Sharma A, et al
    Linear Polyethylenimine-DNA Nanoconstruct for Corneal Gene Delivery.
    J Ocul Pharmacol Ther. 2019;35:23-31.
    PubMed     Text format     Abstract available



  63. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Duran, L., Olvera-Montano, O., Mercado-Sesma, A
    J Ocul Pharmacol Ther. 2019;35:76.
    PubMed     Text format    


    December 2018
  64. ZHANG J, Zhou K, Zhang X, Zhou Y, et al
    Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-kappaB Signaling.
    J Ocul Pharmacol Ther. 2018 Dec 31. doi: 10.1089/jop.2018.0092.
    PubMed     Text format     Abstract available


  65. YATES KA, Shanks RMQ, Kowalski RP, Romanowski EG, et al
    The In Vitro Evaluation of Povidone-Iodine Against Multiple Ocular Adenoviral Types.
    J Ocul Pharmacol Ther. 2018 Dec 27. doi: 10.1089/jop.2018.0122.
    PubMed     Text format     Abstract available


  66. WOODWARD DF, Wang JW, Ni M, Bauer AJ, et al
    In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis.
    J Ocul Pharmacol Ther. 2018 Dec 14. doi: 10.1089/jop.2018.0077.
    PubMed     Text format     Abstract available


    November 2018
  67. RANGARAJAN R, Ketelson H
    Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium.
    J Ocul Pharmacol Ther. 2018 Nov 29. doi: 10.1089/jop.2018.0031.
    PubMed     Text format     Abstract available


  68. CALLANAN D, Kunimoto D, Maturi RK, Patel SS, et al
    Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2018 Nov 9. doi: 10.1089/jop.2018.0062.
    PubMed     Text format     Abstract available


  69. EKANAYAKA SA, McClellan SA, Peng X, Barrett RP, et al
    HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0073.
    PubMed     Text format     Abstract available


  70. LAKHANI P, Patil A, Majumdar S
    Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.
    J Ocul Pharmacol Ther. 2018 Nov 8. doi: 10.1089/jop.2018.0089.
    PubMed     Text format     Abstract available


  71. HOUBEN I, De Zaeytijd J, Deghislage C, Frost NA, et al
    Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy.
    J Ocul Pharmacol Ther. 2018 Nov 7. doi: 10.1089/jop.2018.0012.
    PubMed     Text format     Abstract available


    October 2018
  72. CELIKER H, Kazokoglu H, Direskeneli H
    Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a.
    J Ocul Pharmacol Ther. 2018 Oct 25. doi: 10.1089/jop.2018.0083.
    PubMed     Text format     Abstract available


  73. REE YS, Back HM, Yun HY, Ahn JH, et al
    Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric Patients with Retinoblastoma.
    J Ocul Pharmacol Ther. 2018 Oct 18. doi: 10.1089/jop.2018.0041.
    PubMed     Text format     Abstract available


  74. SZEGEDI S, Scheschy U, Schmidl D, Aranha Dos Santos V, et al
    Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0069.
    PubMed     Text format     Abstract available


  75. LA GATTA A, Corsuto L, Salzillo R, D'Agostino A, et al
    In Vitro Evaluation of Hybrid Cooperative Complexes of Hyaluronic Acid as a Potential New Ophthalmic Treatment.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0046.
    PubMed     Text format     Abstract available


  76. MOON I, Kang HG, Yeo A, Noh H, et al
    Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
    J Ocul Pharmacol Ther. 2018 Oct 16. doi: 10.1089/jop.2018.0005.
    PubMed     Text format     Abstract available


  77. GOLDSTEIN AS, Aldrich BT, Skeie JM, Schmidt GA, et al
    Assessing the Effects of Ripasudil, a Novel Rho Kinase Inhibitor, on Human Corneal Endothelial Cell Health.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0063.
    PubMed     Text format     Abstract available


  78. DAULL P, Raymond E, Feraille L, Garrigue JS, et al
    Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.
    J Ocul Pharmacol Ther. 2018 Oct 12. doi: 10.1089/jop.2018.0040.
    PubMed     Text format     Abstract available


  79. CHUN YH, Beak JU, Kim HS, Na KS, et al
    Topical Cyclosporine Pretreatment of Ocular Surface in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    J Ocul Pharmacol Ther. 2018 Oct 5. doi: 10.1089/jop.2018.0006.
    PubMed     Text format     Abstract available


    September 2018
  80. TORIYAMA K, Suzuki T, Shiraishi A
    Characteristics of Infectious Keratitis in Old and Very Old Patients.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0028.
    PubMed     Text format     Abstract available


  81. YOON CH, Park JW, Ryu JS, Kim MK, et al
    Corneal Toxicity of Topical Tacrolimus Ointment in Mice with Corneal Epithelial Injury.
    J Ocul Pharmacol Ther. 2018 Sep 15. doi: 10.1089/jop.2018.0054.
    PubMed     Text format     Abstract available


  82. BOZIC M, Stojkovic M, Knezevic M, Marjanovic I, et al
    Is the Use of Refrigerated Fixed Combination of Dorzolamide 2%-Timolol 0.5% (COSOPT) Associated with Less Ocular Discomfort? A Pilot Study.
    J Ocul Pharmacol Ther. 2018 Sep 11. doi: 10.1089/jop.2018.0023.
    PubMed     Text format     Abstract available


  83. SEIBOLD LK, Wagner BD, Lynch AM, Kahook MY, et al
    The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy.
    J Ocul Pharmacol Ther. 2018 Sep 7. doi: 10.1089/jop.2018.0050.
    PubMed     Text format     Abstract available


  84. WILL-ORREGO A, Qiu Y, Fassbender ES, Shen S, et al
    Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
    J Ocul Pharmacol Ther. 2018;34:489-499.
    PubMed     Text format     Abstract available


    August 2018
  85. GADE SK, Shivshetty N, Sharma N, Bhatnagar S, et al
    Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    J Ocul Pharmacol Ther. 2018 Aug 23. doi: 10.1089/jop.2018.0059.
    PubMed     Text format     Abstract available


  86. REZKALLAH A, Malcles A, Dot C, Voirin N, et al
    Evaluation of Efficacy and Safety of Dexamethasone Intravitreal Implants of Vitrectomized and Nonvitrectomized Eyes in a Real-World Study.
    J Ocul Pharmacol Ther. 2018 Aug 17. doi: 10.1089/jop.2018.0007.
    PubMed     Text format     Abstract available


  87. GARCIA-FEIJOO J, Hoh H, Uzunov R, Dickerson JE Jr, et al
    Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial.
    J Ocul Pharmacol Ther. 2018 Aug 3. doi: 10.1089/jop.2018.0036.
    PubMed     Text format     Abstract available


    July 2018
  88. LIN YC, Horng LY, Sung HC, Wu RT, et al
    Sodium Iodate Disrupted the Mitochondrial-Lysosomal Axis in Cultured Retinal Pigment Epithelial Cells.
    J Ocul Pharmacol Ther. 2018 Jul 18. doi: 10.1089/jop.2017.0073.
    PubMed     Text format     Abstract available


  89. FRAUNFELDER FT, Fraunfelder FW
    Oral Anti-Vascular Endothelial Growth Factor Drugs and Ocular Side Effects.
    J Ocul Pharmacol Ther. 2018 Jul 13. doi: 10.1089/jop.2018.0019.
    PubMed     Text format     Abstract available


  90. FUWA M, Toris CB, Fan S, Taniguchi T, et al
    Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
    J Ocul Pharmacol Ther. 2018 Jul 10. doi: 10.1089/jop.2017.0146.
    PubMed     Text format     Abstract available


  91. AIHARA M
    Response to Novack re: "Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes".
    J Ocul Pharmacol Ther. 2018;34:431.
    PubMed     Text format    


    June 2018
  92. GUIMARAES DE SOUZA R, Yu Z, Stern ME, Pflugfelder SC, et al
    Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.
    J Ocul Pharmacol Ther. 2018 Jun 29. doi: 10.1089/jop.2018.0047.
    PubMed     Text format     Abstract available


  93. NOVACK GD
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jun 20. doi: 10.1089/jop.2018.0048.
    PubMed     Text format    


    May 2018
  94. KAKIMOTO H, Takamura Y, Arimura S, Miyake S, et al
    Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 29. doi: 10.1089/jop.2017.0109.
    PubMed     Text format     Abstract available


  95. ZHAO X, Tong Y, Wang X, Zhang X, et al
    Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 24. doi: 10.1089/jop.2017.0139.
    PubMed     Text format     Abstract available


  96. CHAKRAVARTI T
    The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India.
    J Ocul Pharmacol Ther. 2018 May 15. doi: 10.1089/jop.2017.0135.
    PubMed     Text format     Abstract available


  97. CHO YK, Shin EY, Uehara H, Ambati B, et al
    The Effect of 0.5% Timolol Maleate on Corneal(Lymph)Angiogenesis in a Murine Suture Model.
    J Ocul Pharmacol Ther. 2018 May 14. doi: 10.1089/jop.2017.0119.
    PubMed     Text format     Abstract available


  98. TRAN HDM, Tran YH, Tran TD, Jong M, et al
    A Review of Myopia Control with Atropine.
    J Ocul Pharmacol Ther. 2018 May 1. doi: 10.1089/jop.2017.0144.
    PubMed     Text format     Abstract available


    April 2018
  99. SMITH A, Pawar M, Van Dort ME, Galban S, et al
    Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0126.
    PubMed     Text format     Abstract available


  100. GARAY-ARAMBURU G, Gomez-Moreno A
    A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0148.
    PubMed     Text format     Abstract available


  101. BAIZA-DURAN L, Olvera-Montano O, Mercado-Sesma AR, Oregon-Miranda AA, et al
    Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2018;34:250-255.
    PubMed     Text format     Abstract available


    March 2018
  102. RUANGVARAVATE N, Prabhasawat P, Vachirasakchai V, Tantimala R, et al
    High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    J Ocul Pharmacol Ther. 2018 Mar 29. doi: 10.1089/jop.2017.0104.
    PubMed     Text format     Abstract available


  103. ZHU S, Xu X, Liu K, Gu Q, et al
    PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-kappaB/p38 Pathway.
    J Ocul Pharmacol Ther. 2018 Mar 27. doi: 10.1089/jop.2017.0068.
    PubMed     Text format     Abstract available


    February 2018
  104. NOVACK GD, Moyer ED
    Slit Lamp-Based Ocular Scoring Systems: Commentary.
    J Ocul Pharmacol Ther. 2018 Feb 26. doi: 10.1089/jop.2018.29039.
    PubMed     Text format    


  105. KAZEMI A, McLaren JW, Kopczynski CC, Heah TG, et al
    The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
    J Ocul Pharmacol Ther. 2018 Feb 22. doi: 10.1089/jop.2017.0138.
    PubMed     Text format     Abstract available


  106. OZGONUL C, Dedania VS, Besirli CG
    Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0074.
    PubMed     Text format     Abstract available


  107. UCAN GUNDUZ G, Parmak Yener N, Kilincel O, Gunduz C, et al
    How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0133.
    PubMed     Text format     Abstract available


  108. PAPANGKORN K, Higuchi JW, Brar B, Higuchi WI, et al
    Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    J Ocul Pharmacol Ther. 2018 Feb 12. doi: 10.1089/jop.2017.0093.
    PubMed     Text format     Abstract available


  109. BACHU RD, Stepanski M, Alzhrani RM, Jung R, et al
    Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration.
    J Ocul Pharmacol Ther. 2018 Feb 6. doi: 10.1089/jop.2017.0082.
    PubMed     Text format     Abstract available


  110. CARLSON E, Kao WWY, Ogundele A
    Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model.
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0080.
    PubMed     Text format     Abstract available



  111. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsir
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0030.
    PubMed     Text format    


  112. DINC E, Ayaz L, Kurt AH
    Effects of Bevacizumab, Ranibizumab, and Aflibercept on MicroRNA Expression in a Retinal Pigment Epithelium Cell Culture Model of Oxidative Stress.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0128.
    PubMed     Text format     Abstract available


  113. YAZICI A, Sari E, Ayhan E, Sahin G, et al
    The Effect of Low-Dose Aspirin on Dry Eye Parameters and Ocular Surface Disease Index Questionnaire.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0064.
    PubMed     Text format     Abstract available


    January 2018
  114. KARACA ADIYEKE S, Ture G, Talay E
    Intravitreal Dexamethasone Implant for Postvitrectomy Macular Edema: A Retrospective Cohort of 14 Patients (Postvitrectomy Macular Edema Treatment).
    J Ocul Pharmacol Ther. 2018 Jan 29. doi: 10.1089/jop.2017.0107.
    PubMed     Text format     Abstract available


  115. NJIE-MBYE YF, Robinson J, Mitchell-Bush L, Mckoy M, et al
    Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
    J Ocul Pharmacol Ther. 2018 Jan 25. doi: 10.1089/jop.2017.0124.
    PubMed     Text format     Abstract available


  116. OHIA SE, Njie-Mbye YF, Robinson J, Mitchell L, et al
    Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
    J Ocul Pharmacol Ther. 2018 Jan 24. doi: 10.1089/jop.2017.0123.
    PubMed     Text format     Abstract available


  117. SINGH S, Agarwal R, Abdul Razak Z, Ngu R, et al
    Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
    J Ocul Pharmacol Ther. 2018 Jan 17. doi: 10.1089/jop.2017.0098.
    PubMed     Text format     Abstract available


  118. SHARIF NA
    iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0125.
    PubMed     Text format     Abstract available


  119. SEKINE Y, Shimada M, Satake S, Okubo M, et al
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0091.
    PubMed     Text format     Abstract available


  120. JIN SW, Lee SM
    The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    J Ocul Pharmacol Ther. 2018 Jan 3. doi: 10.1089/jop.2017.0075.
    PubMed     Text format     Abstract available


    December 2017
  121. CHUNG JK, Spencer E, Hunt M, McCauley T, et al
    Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    J Ocul Pharmacol Ther. 2017 Dec 21. doi: 10.1089/jop.2017.0106.
    PubMed     Text format     Abstract available


  122. EKANAYAKA SA, McClellan SA, Barrett RP, Hazlett LD, et al
    Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
    J Ocul Pharmacol Ther. 2017 Dec 13. doi: 10.1089/jop.2017.0094.
    PubMed     Text format     Abstract available


  123. WATERBURY LD
    Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.
    J Ocul Pharmacol Ther. 2017 Dec 11. doi: 10.1089/jop.2017.0048.
    PubMed     Text format     Abstract available


  124. OHIA SE, Robinson J, Mitchell L, Ngele KK, et al
    Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.
    J Ocul Pharmacol Ther. 2017 Dec 7. doi: 10.1089/jop.2017.0077.
    PubMed     Text format     Abstract available


  125. SCHMITT HM, Schlamp CL, Nickells RW
    Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0059.
    PubMed     Text format     Abstract available


  126. KHAN S, Warade S, Singhavi DJ
    Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0079.
    PubMed     Text format     Abstract available


  127. HARTMAN RR, Kompella UB
    Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.
    J Ocul Pharmacol Ther. 2017 Dec 5. doi: 10.1089/jop.2017.0121.
    PubMed     Text format     Abstract available


  128. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    J Ocul Pharmacol Ther. 2017;33:718-734.
    PubMed     Text format     Abstract available


    November 2017
  129. MASUOKA T, Gallar J, Belmonte C
    Inhibitory Effect of Amitriptyline on the Impulse Activity of Cold Thermoreceptor Terminals of Intact and Tear-Deficient Guinea Pig Corneas.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0066.
    PubMed     Text format     Abstract available


  130. CHEN Y, Hua R
    Therapeutic Efficacy of Conbercept for Inflammatory Choroidal Neovascularization.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0097.
    PubMed     Text format    


  131. BANTSEEV V, Erickson R, Leipold D, Amaya C, et al
    Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0063.
    PubMed     Text format     Abstract available


  132. MIOTTO S, Zemella N, Gusson E, Panozzo G, et al
    Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0022.
    PubMed     Text format     Abstract available


  133. SUWANNOI P, Chomnawang M, Sarisuta N, Reichl S, et al
    Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0057.
    PubMed     Text format     Abstract available


  134. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0021.
    PubMed     Text format     Abstract available


  135. DI ZAZZO A, Roberti G, Mashaghi A, Abud TB, et al
    Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    J Ocul Pharmacol Ther. 2017;33:670-677.
    PubMed     Text format     Abstract available


    October 2017
  136. PAPANGKORN K, Prendergast E, Higuchi JW, Brar B, et al
    Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    J Ocul Pharmacol Ther. 2017 Oct 12. doi: 10.1089/jop.2017.0053.
    PubMed     Text format     Abstract available


  137. MOUSTAFA MT, Ramirez C, Schneider K, Atilano SR, et al
    Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Muller Cells.
    J Ocul Pharmacol Ther. 2017;33:610-619.
    PubMed     Text format     Abstract available


    September 2017
  138. GARWEG JG, Niderprim SA, Russ HM, Pfister IB, et al
    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006.
    PubMed     Text format     Abstract available


  139. LIN CJ, Chen HS, Su CW, Tien PT, et al
    The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    J Ocul Pharmacol Ther. 2017 Sep 26. doi: 10.1089/jop.2017.0070.
    PubMed     Text format     Abstract available


  140. CORCORAN P, Hollander DA, Ousler GW 3rd, Angjeli E, et al
    Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


  141. GUERRA M, Marques S, Quadrado Gil J, Campos J, et al
    Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


    July 2017
  142. PENG SY, Lai CC, Wang NK, Wu WC, et al
    Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:466-472.
    PubMed     Text format     Abstract available


    June 2017
  143. BARANOV P, Lin H, McCabe K, Gale D, et al
    A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.
    J Ocul Pharmacol Ther. 2017;33:412-422.
    PubMed     Text format     Abstract available


  144. ROLANDO M, Vagge A
    Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:383-390.
    PubMed     Text format     Abstract available


  145. SANCHEZ-AVILA RM, Merayo-Lloves J, Riestra AC, Anitua E, et al
    The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:391-399.
    PubMed     Text format     Abstract available


    May 2017
  146. TERADA Y, Kamoi K, Komizo T, Miyata K, et al
    Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    J Ocul Pharmacol Ther. 2017;33:216-223.
    PubMed     Text format     Abstract available


  147. WEI JR, Wen X, Bible PW, Li Z, et al
    Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.
    J Ocul Pharmacol Ther. 2017;33:285-289.
    PubMed     Text format     Abstract available


    April 2017
  148. RUBSAM A, Thieme CE, Schlomberg J, Winterhalter S, et al
    Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:141-148.
    PubMed     Text format     Abstract available


  149. SELEN F, Tekeli O, Yanik O
    Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
    J Ocul Pharmacol Ther. 2017;33:170-175.
    PubMed     Text format     Abstract available


    March 2017
  150. BAO X, Hou M, Qin Y, Luo F, et al
    Effect of an MG132-Sustained Drug Delivery Capsular Ring on the Inhibition of Posterior Capsule Opacification in a Rabbit Model.
    J Ocul Pharmacol Ther. 2017;33:103-110.
    PubMed     Text format     Abstract available


  151. TORKILDSEN G, Abelson MB, Gomes PJ, McLaurin E, et al
    Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    J Ocul Pharmacol Ther. 2017;33:79-90.
    PubMed     Text format     Abstract available


  152. PARK Y, Song JS, Choi CY, Yoon KC, et al
    A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    J Ocul Pharmacol Ther. 2017;33:66-72.
    PubMed     Text format     Abstract available


    January 2017
  153. PFLUGFELDER SC, Stern M, Zhang S, Shojaei A, et al
    LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2017;33:5-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: